What is ING Source?
ING Source Inc. operates at the intersection of advanced textile engineering and orthopedic health. By leveraging patented manufacturing processes, the company produces high-performance compression products designed to improve patient outcomes and consumer mobility. The firm manages a robust portfolio, most notably the OS1st brand, which has established a dominant footprint within the United States specialty retail market through strategic partnerships with independent retailers. Furthermore, the company maintains a strong digital presence via its OrthoSleeve brand, facilitating direct-to-consumer access to its specialized bracing solutions and compression hosiery. This dual-channel distribution strategy allows ING Source to maintain high brand equity while addressing the growing demand for non-invasive pain management and recovery tools.
How much funding has ING Source raised?
ING Source has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in ING Source
PPP
Public-Private Partnership
What's next for ING Source?
Following this late-stage financing, ING Source is well-positioned to accelerate its market penetration and operational efficiency. The capital will likely be deployed to enhance supply chain resilience and expand the research and development pipeline for next-generation compression materials. As the company navigates the complexities of the medical-grade consumer goods market, the focus will remain on scaling the OS1st and OrthoSleeve brands to capture additional market share. By prioritizing innovation in textile engineering, ING Source aims to maintain its competitive advantage, ensuring that its bracing solutions remain the gold standard for retailers and consumers seeking effective, evidence-based orthopedic support.
See full ING Source company page
